227. オスラー病 Osler disease Clinical trials / Disease details

臨床試験数 : 56 / 薬物数 : 72 - (DrugBank : 21) / 標的遺伝子数 : 23 - 標的パスウェイ数 : 136

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01485224 (ClinicalTrials.gov)	November 2011	28/11/2011	Efficacy of Thalidomide in the Treatment of Hereditary Hemorrhagic Telangiectasia	Efficacy of Thalidomidein the Treatment of Severe Recurrent Epistaxis in Hereditary Hemorrhagic Tela ...	Hereditary Hemorrhagic Telangiectasia;Epistaxis	Drug: Thalidomide	IRCCS Policlinico S. Matteo	NULL	Completed	18 Years	N/A	All	31	Phase 2	Italy
2	EUCTR2011-004096-36-IT (EUCTR)	11/10/2011	19/03/2012	Efficacy of thalidomidein the treatment of heavy and frequent nose bleeding in patients affected by ...	Efficacy of thalidomidein the treatment of severe recurrent epistaxis in hereditary hemorrhagic tela ...	Severe recurrent epistaxis in hereditary hemorrhagic telangiectasia MedDRA version: 14.1;Level: LLT; ...	Trade Name: THALIDOMIDE CELGENE*28CPS 50MG INN or Proposed INN: THALIDOMIDE	OSPEDALE POLICLINICO S. MATTEO	NULL	Not Recruiting			Female: yes Male: yes	31	Phase 2	Italy
3	NCT00389935 (ClinicalTrials.gov)	October 2006	17/10/2006	Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding	Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding	Arteriovenous Malformation;Hereditary Hemorrhagic Telangiectasia;Hematochezia;Melena	Drug: Thalidomide	Northport Veterans Affairs Medical Center	Georgia Regents University;University of Massachusetts, Worcester	Completed	18 Years	N/A	Both	14	Phase 2	United States

First Previous1Next Last